Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial.
Nanna LindMerete Bechmann ChristensenDorte L HansenKirsten NørgaardPublished in: Diabetes care (2024)
In adults with inadequately controlled insulin-treated type 2 diabetes, the 12-month impact of CGM was superior to BGM in improving glucose control and other crucial health parameters. The findings support the use of CGM in the insulin-treated subgroup of type 2 diabetes.
Keyphrases
- type diabetes
- glycemic control
- blood glucose
- randomized controlled trial
- insulin resistance
- healthcare
- public health
- cardiovascular disease
- weight loss
- mental health
- clinical trial
- newly diagnosed
- systematic review
- risk assessment
- skeletal muscle
- adipose tissue
- metabolic syndrome
- blood pressure
- social media
- human health
- open label
- double blind